共 50 条
- [3] Tailoring chemoimmunotherapy de-escalation in early-stage triple-negative breast cancer LANCET ONCOLOGY, 2025, 26 (03): : 273 - 274
- [8] Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2 + Breast Cancer Current Oncology Reports, 2022, 24 : 1779 - 1789